Position
Forefront Analytics, LLC in Thermo Fisher Scientific Inc.
Back to the book · All holders of TMO
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$50.8K$579.27 → $491.46
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 586 | $339.5K | — | — | — | 0.3% |
| Q1 2026 | 579 | $284.6K | $491.46 | −$50.8K | −$4.05K | 0.3% |